Peapack Gladstone Financial Corp Decreases Stock Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Peapack Gladstone Financial Corp lowered its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHEFree Report) by 2.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,299 shares of the company’s stock after selling 309 shares during the period. Peapack Gladstone Financial Corp owned approximately 0.75% of iShares U.S. Pharmaceuticals ETF worth $2,836,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in IHE. Capital Analysts LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at approximately $198,000. Chevy Chase Trust Holdings LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter worth approximately $1,881,000. Raymond James Financial Services Advisors Inc. raised its holdings in iShares U.S. Pharmaceuticals ETF by 337.2% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 16,418 shares of the company’s stock valued at $3,044,000 after acquiring an additional 12,663 shares in the last quarter. Essex Savings Bank bought a new position in iShares U.S. Pharmaceuticals ETF during the 4th quarter valued at $204,000. Finally, Welch Group LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter worth about $657,000.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of IHE stock opened at $66.35 on Friday. The stock has a market capitalization of $670.14 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a one year low of $55.36 and a one year high of $69.56. The company’s 50-day simple moving average is $65.24 and its 200-day simple moving average is $64.42.

About iShares U.S. Pharmaceuticals ETF

(Free Report)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Recommended Stories

Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHEFree Report).

Institutional Ownership by Quarter for iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Receive News & Ratings for iShares U.S. Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.